The global market for OTC Anti-Infective Medicine was estimated to be worth US$ 13730 million in 2023 and is forecast to a readjusted size of US$ 17370 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030

OTC Anti-Infective Medicine - Market

Anti-infectives are medicines that work to prevent or treat infections, they include antibacterials, antivirals, antifungals and antiparasitic medications.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Medicine, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of OTC Anti-Infective Medicine by region & country, by Type, and by Application.

The OTC Anti-Infective Medicine market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Medicine.

Market Segmentation

Scope of OTC Anti-Infective Medicine - Market Report

Report Metric	Details
Report Name	OTC Anti-Infective Medicine - Market
Forecasted market size in 2030	US$ 17370 million
CAGR	3.4%
Forecasted years	2024 - 2030
Segment by Type:	Antibacterials Medicine Antivirals Medicine Antifungals Medicine Antiparasitic Medicine
Segment by Application	Hospital Retail Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of OTC Anti-Infective Medicine manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of OTC Anti-Infective Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of OTC Anti-Infective Medicine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the OTC Anti-Infective Medicine - Market size in 2030?

Ans: The OTC Anti-Infective Medicine - Market size in 2030 will be US$ 17370 million.

Who are the main players in the OTC Anti-Infective Medicine - Market report?

Ans: The main players in the OTC Anti-Infective Medicine - Market are GlaxoSmithKline, Merck, Pfizer, Novartis, Abbott, Sanofi, Bristol-Myers Squibb, Roche

What are the Application segmentation covered in the OTC Anti-Infective Medicine - Market report?

Ans: The Applications covered in the OTC Anti-Infective Medicine - Market report are Hospital, Retail Pharmacy

What are the Type segmentation covered in the OTC Anti-Infective Medicine - Market report?

Ans: The Types covered in the OTC Anti-Infective Medicine - Market report are Antibacterials Medicine, Antivirals Medicine, Antifungals Medicine, Antiparasitic Medicine

1 Market Overview

1.1 OTC Anti-Infective Medicine Product Introduction

1.2 Global OTC Anti-Infective Medicine Market Size Forecast

1.3 OTC Anti-Infective Medicine Market Trends & Drivers

1.3.1 OTC Anti-Infective Medicine Industry Trends

1.3.2 OTC Anti-Infective Medicine Market Drivers & Opportunity

1.3.3 OTC Anti-Infective Medicine Market Challenges

1.3.4 OTC Anti-Infective Medicine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global OTC Anti-Infective Medicine Players Revenue Ranking (2023)

2.2 Global OTC Anti-Infective Medicine Revenue by Company (2019-2024)

2.3 Key Companies OTC Anti-Infective Medicine Manufacturing Base Distribution and Headquarters

2.4 Key Companies OTC Anti-Infective Medicine Product Offered

2.5 Key Companies Time to Begin Mass Production of OTC Anti-Infective Medicine

2.6 OTC Anti-Infective Medicine Market Competitive Analysis

2.6.1 OTC Anti-Infective Medicine Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by OTC Anti-Infective Medicine Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medicine as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Antibacterials Medicine

3.1.2 Antivirals Medicine

3.1.3 Antifungals Medicine

3.1.4 Antiparasitic Medicine

3.2 Global OTC Anti-Infective Medicine Sales Value by Type

3.2.1 Global OTC Anti-Infective Medicine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global OTC Anti-Infective Medicine Sales Value, by Type (2019-2030)

3.2.3 Global OTC Anti-Infective Medicine Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.2 Global OTC Anti-Infective Medicine Sales Value by Application

4.2.1 Global OTC Anti-Infective Medicine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global OTC Anti-Infective Medicine Sales Value, by Application (2019-2030)

4.2.3 Global OTC Anti-Infective Medicine Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global OTC Anti-Infective Medicine Sales Value by Region

5.1.1 Global OTC Anti-Infective Medicine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global OTC Anti-Infective Medicine Sales Value by Region (2019-2024)

5.1.3 Global OTC Anti-Infective Medicine Sales Value by Region (2025-2030)

5.1.4 Global OTC Anti-Infective Medicine Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America OTC Anti-Infective Medicine Sales Value, 2019-2030

5.2.2 North America OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe OTC Anti-Infective Medicine Sales Value, 2019-2030

5.3.2 Europe OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific OTC Anti-Infective Medicine Sales Value, 2019-2030

5.4.2 Asia Pacific OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America OTC Anti-Infective Medicine Sales Value, 2019-2030

5.5.2 South America OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa OTC Anti-Infective Medicine Sales Value, 2019-2030

5.6.2 Middle East & Africa OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions OTC Anti-Infective Medicine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions OTC Anti-Infective Medicine Sales Value

6.3 United States

6.3.1 United States OTC Anti-Infective Medicine Sales Value, 2019-2030

6.3.2 United States OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe OTC Anti-Infective Medicine Sales Value, 2019-2030

6.4.2 Europe OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China OTC Anti-Infective Medicine Sales Value, 2019-2030

6.5.2 China OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.5.3 China OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan OTC Anti-Infective Medicine Sales Value, 2019-2030

6.6.2 Japan OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea OTC Anti-Infective Medicine Sales Value, 2019-2030

6.7.2 South Korea OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia OTC Anti-Infective Medicine Sales Value, 2019-2030

6.8.2 Southeast Asia OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India OTC Anti-Infective Medicine Sales Value, 2019-2030

6.9.2 India OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

6.9.3 India OTC Anti-Infective Medicine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Profile

7.1.2 GlaxoSmithKline Main Business

7.1.3 GlaxoSmithKline OTC Anti-Infective Medicine Products, Services and Solutions

7.1.4 GlaxoSmithKline OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.1.5 GlaxoSmithKline Recent Developments

7.2 Merck

7.2.1 Merck Profile

7.2.2 Merck Main Business

7.2.3 Merck OTC Anti-Infective Medicine Products, Services and Solutions

7.2.4 Merck OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.2.5 Merck Recent Developments

7.3 Pfizer

7.3.1 Pfizer Profile

7.3.2 Pfizer Main Business

7.3.3 Pfizer OTC Anti-Infective Medicine Products, Services and Solutions

7.3.4 Pfizer OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.3.5 Novartis Recent Developments

7.4 Novartis

7.4.1 Novartis Profile

7.4.2 Novartis Main Business

7.4.3 Novartis OTC Anti-Infective Medicine Products, Services and Solutions

7.4.4 Novartis OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.4.5 Novartis Recent Developments

7.5 Abbott

7.5.1 Abbott Profile

7.5.2 Abbott Main Business

7.5.3 Abbott OTC Anti-Infective Medicine Products, Services and Solutions

7.5.4 Abbott OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.5.5 Abbott Recent Developments

7.6 Sanofi

7.6.1 Sanofi Profile

7.6.2 Sanofi Main Business

7.6.3 Sanofi OTC Anti-Infective Medicine Products, Services and Solutions

7.6.4 Sanofi OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.6.5 Sanofi Recent Developments

7.7 Bristol-Myers Squibb

7.7.1 Bristol-Myers Squibb Profile

7.7.2 Bristol-Myers Squibb Main Business

7.7.3 Bristol-Myers Squibb OTC Anti-Infective Medicine Products, Services and Solutions

7.7.4 Bristol-Myers Squibb OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.7.5 Bristol-Myers Squibb Recent Developments

7.8 Roche

7.8.1 Roche Profile

7.8.2 Roche Main Business

7.8.3 Roche OTC Anti-Infective Medicine Products, Services and Solutions

7.8.4 Roche OTC Anti-Infective Medicine Revenue (US$ Million) & (2019-2024)

7.8.5 Roche Recent Developments

8 Industry Chain Analysis

8.1 OTC Anti-Infective Medicine Industrial Chain

8.2 OTC Anti-Infective Medicine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 OTC Anti-Infective Medicine Sales Model

8.5.2 Sales Channel

8.5.3 OTC Anti-Infective Medicine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. OTC Anti-Infective Medicine Market Trends

Table 2. OTC Anti-Infective Medicine Market Drivers & Opportunity

Table 3. OTC Anti-Infective Medicine Market Challenges

Table 4. OTC Anti-Infective Medicine Market Restraints

Table 5. Global OTC Anti-Infective Medicine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global OTC Anti-Infective Medicine Revenue Market Share by Company (2019-2024)

Table 7. Key Companies OTC Anti-Infective Medicine Manufacturing Base Distribution and Headquarters

Table 8. Key Companies OTC Anti-Infective Medicine Product Type

Table 9. Key Companies Time to Begin Mass Production of OTC Anti-Infective Medicine

Table 10. Global OTC Anti-Infective Medicine Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Medicine as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global OTC Anti-Infective Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global OTC Anti-Infective Medicine Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global OTC Anti-Infective Medicine Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global OTC Anti-Infective Medicine Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global OTC Anti-Infective Medicine Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global OTC Anti-Infective Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global OTC Anti-Infective Medicine Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global OTC Anti-Infective Medicine Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global OTC Anti-Infective Medicine Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global OTC Anti-Infective Medicine Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global OTC Anti-Infective Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global OTC Anti-Infective Medicine Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global OTC Anti-Infective Medicine Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global OTC Anti-Infective Medicine Sales Value by Region (2019-2024) & (%)

Table 27. Global OTC Anti-Infective Medicine Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions OTC Anti-Infective Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions OTC Anti-Infective Medicine Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions OTC Anti-Infective Medicine Sales Value, (2025-2030) & (US$ Million)

Table 31. GlaxoSmithKline Basic Information List

Table 32. GlaxoSmithKline Description and Business Overview

Table 33. GlaxoSmithKline OTC Anti-Infective Medicine Products, Services and Solutions

Table 34. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of GlaxoSmithKline (2019-2024)

Table 35. GlaxoSmithKline Recent Developments

Table 36. Merck Basic Information List

Table 37. Merck Description and Business Overview

Table 38. Merck OTC Anti-Infective Medicine Products, Services and Solutions

Table 39. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Merck (2019-2024)

Table 40. Merck Recent Developments

Table 41. Pfizer Basic Information List

Table 42. Pfizer Description and Business Overview

Table 43. Pfizer OTC Anti-Infective Medicine Products, Services and Solutions

Table 44. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Pfizer (2019-2024)

Table 45. Pfizer Recent Developments

Table 46. Novartis Basic Information List

Table 47. Novartis Description and Business Overview

Table 48. Novartis OTC Anti-Infective Medicine Products, Services and Solutions

Table 49. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Novartis (2019-2024)

Table 50. Novartis Recent Developments

Table 51. Abbott Basic Information List

Table 52. Abbott Description and Business Overview

Table 53. Abbott OTC Anti-Infective Medicine Products, Services and Solutions

Table 54. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Abbott (2019-2024)

Table 55. Abbott Recent Developments

Table 56. Sanofi Basic Information List

Table 57. Sanofi Description and Business Overview

Table 58. Sanofi OTC Anti-Infective Medicine Products, Services and Solutions

Table 59. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Sanofi (2019-2024)

Table 60. Sanofi Recent Developments

Table 61. Bristol-Myers Squibb Basic Information List

Table 62. Bristol-Myers Squibb Description and Business Overview

Table 63. Bristol-Myers Squibb OTC Anti-Infective Medicine Products, Services and Solutions

Table 64. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Bristol-Myers Squibb (2019-2024)

Table 65. Bristol-Myers Squibb Recent Developments

Table 66. Roche Basic Information List

Table 67. Roche Description and Business Overview

Table 68. Roche OTC Anti-Infective Medicine Products, Services and Solutions

Table 69. Revenue (US$ Million) in OTC Anti-Infective Medicine Business of Roche (2019-2024)

Table 70. Roche Recent Developments

Table 71. Key Raw Materials Lists

Table 72. Raw Materials Key Suppliers Lists

Table 73. OTC Anti-Infective Medicine Downstream Customers

Table 74. OTC Anti-Infective Medicine Distributors List

Table 75. Research Programs/Design for This Report

Table 76. Key Data Information from Secondary Sources

Table 77. Key Data Information from Primary Sources

Table 78. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. OTC Anti-Infective Medicine Product Picture

Figure 2. Global OTC Anti-Infective Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 4. OTC Anti-Infective Medicine Report Years Considered

Figure 5. Global OTC Anti-Infective Medicine Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by OTC Anti-Infective Medicine Revenue in 2023

Figure 7. OTC Anti-Infective Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Antibacterials Medicine Picture

Figure 9. Antivirals Medicine Picture

Figure 10. Antifungals Medicine Picture

Figure 11. Antiparasitic Medicine Picture

Figure 12. Global OTC Anti-Infective Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global OTC Anti-Infective Medicine Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospital

Figure 15. Product Picture of Retail Pharmacy

Figure 16. Global OTC Anti-Infective Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global OTC Anti-Infective Medicine Sales Value Market Share by Application, 2023 & 2030

Figure 18. North America OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 19. North America OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

Figure 20. Europe OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 21. Europe OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

Figure 22. Asia Pacific OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 23. Asia Pacific OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

Figure 24. South America OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 25. South America OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

Figure 26. Middle East & Africa OTC Anti-Infective Medicine Sales Value (2019-2030) & (US$ Million)

Figure 27. Middle East & Africa OTC Anti-Infective Medicine Sales Value by Country (%), 2023 VS 2030

Figure 28. Key Countries/Regions OTC Anti-Infective Medicine Sales Value (%), (2019-2030)

Figure 29. United States OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 30. United States OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 31. United States OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 32. Europe OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 33. Europe OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 34. Europe OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 35. China OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 36. China OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 37. China OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 38. Japan OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 39. Japan OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 40. Japan OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 41. South Korea OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 42. South Korea OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 43. South Korea OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 44. Southeast Asia OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 45. Southeast Asia OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 46. Southeast Asia OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 47. India OTC Anti-Infective Medicine Sales Value, (2019-2030) & (US$ Million)

Figure 48. India OTC Anti-Infective Medicine Sales Value by Type (%), 2023 VS 2030

Figure 49. India OTC Anti-Infective Medicine Sales Value by Application (%), 2023 VS 2030

Figure 50. OTC Anti-Infective Medicine Industrial Chain

Figure 51. OTC Anti-Infective Medicine Manufacturing Cost Structure

Figure 52. Channels of Distribution (Direct Sales, and Distribution)

Figure 53. Bottom-up and Top-down Approaches for This Report

Figure 54. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35Z18485

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28M18423

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Moclobemide Film-coated Tablets - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-9U15196

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global ADHD Medications Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14K1494

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions